MetaCap

Cosmos Health Inc. (COSM)

NASDAQ: COSMHealth CareOther PharmaceuticalsUSD

2.81-0.06 (-2.09%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

COSM stock chart

Technical analysis

Key statistics

All statistics
Market cap
$14.14M
EPS (TTM)
-$13.00
52-week range
2.20 – 14.36
Day range
2.55 – 3.25
Volume / Avg
140.14K / 163.51K
Beta
—

52-week range

$2.20$14.36

COSM stock today

Cosmos Health (COSM) closed at $2.81 on Nov 20, down 2.09% (-$0.06), versus the S&P 500's 3.70% decline. At this level, COSM sits near the bottom of its 52-week range of $2.20 to $14.36: 80.4% below the high and 27.7% above the low. COSM is up 464.3% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 314.5%.

Cosmos Health has posted a net loss over the last twelve months (EPS of -$13.00), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Cosmos Health

Company profile

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names.

Industry
Other Pharmaceuticals
CEO
Mr. Grigorios Siokas
Headquarters
Thessaloniki
Employees
163

Financial highlights

Full financials

In fiscal 2025, Cosmos Health generated $65.3 million in revenue, up 19.9% from fiscal 2024, its 3rd consecutive year of revenue growth. Cosmos Health reported a net loss of $19.1 million, compared with a loss of $16.2 million a year earlier. Gross margin was 12.1% (up from 7.9%) and operating margin -25.6%.

Cosmos Health annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$65.27M$54.43M$53.38M$50.35M$56.24M
Growth+19.93%+1.97%+6.02%-10.48%+1.50%
Net income$-19.14M$-16.18M$-18.54M$-13.83M$-7.96M
EPS (diluted)$-0.63$-1.17$-2.15$-33.16$-23.74

Analyst forecast

Forecast

Consensus

strong_buy

Avg. price target

$4.50+60.14%

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 20, 2026
EPS actual vs est.
$-3.40 vs $-0.80
Surprise
-325.00%

Cosmos Health peers

Health Care sector
COSM peer companies
CompanyPrice% ChgMarket capCompare
MEDSDataMeds AI Inc.1.34+84.14%$7.67Mvs COSM
HKPDCellyan Biotechnology Co. Ltd Class A1.38+2.60%$3.40Mvs COSM
ESYNEnerSyn Global Inc.1.11-0.89%$37.44Mvs COSM
NUSNu Skin Enterprises Inc.3.80+0.80%$184.98Mvs COSM
HLFHerbalife Ltd.15.53-0.26%$1.63Bvs COSM
CAHCardinal Health Inc.272.81+0.17%$63.06Bvs COSM
CORCencora Inc.339.09-0.63%$64.71Bvs COSM
MCKMcKesson Corporation1,069.43+0.68%$123.47Bvs COSM

Indexes, lists and sector

Cosmos Health stock FAQ

What is Cosmos Health's stock price today?

COSM last traded at $2.81 as of Nov 20, 4:00 PM EST, down 2.09% on the day. Prices are delayed at least 15 minutes.

Does Cosmos Health pay a dividend?

No. Cosmos Health does not currently pay a regular cash dividend.

Who is Cosmos Health's CEO?

Mr. Grigorios Siokas is the chief executive officer of Cosmos Health Inc., which has about 163 employees.

Has COSM ever split its stock?

Yes. The most recent COSM stock split was a 1-for-20 split on Nov 13, 2026, one of 2 splits on record.

What is the COSM 52-week high?

The 52-week high for COSM is $14.36 and the 52-week low is $2.20. The stock is currently 80.4% below its high.

Compare COSM